AzTrials
AzTrials

GlycaemiaNCT06825962

The Effect of Hydration on Postprandial Metabolic Responses

A study testing Water intake and Water restriction in people with Glycaemia, run by Loughborough University at 1 site in United Kingdom.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Certain populations, such as industrial workers and endurance athletes are particularly susceptible to dehydration due to exposure to heat for long periods of time causing evaporative water loss via sweating. Read more about this study

Who is it for?
Ages 18 to 45 yearsHealthy volunteers can take part
Conditions the study is for
Glycaemia
What is being tested?
Water intake and Water restriction
Could I receive a placebo?
No, everyone receives an active treatment
How many people
16 participants
Where
1 siteUnited Kingdom
Study dates
Mar 2025to Dec 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 45 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male or female
  • Generally fit and healthy
  • Participate in endurance or intermittent exercise at least 3 times a week or minimum of 150 minutes moderate intensity activity per week

Who cannot join

  • < 18 or > 45
  • Any health condition that may affect study outcomes (e.g., endocrine/liver/renal/cardiovascular disease)
  • Any morbidity that affects ability to cycle
  • Smoker or vaper

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Lewis J James, PhD contact

+44 (0) 1509 226305

L.James@lboro.ac.uk

United Kingdom1 site
  • Loughborough University

    Loughborough, Leicestershire, LE113TU

    Lewis J James, +44 (0) 1509 226305, L.James@lboro.ac.uk

Other trials in United Kingdom

About this study

Certain populations, such as industrial workers and endurance athletes are particularly susceptible to dehydration due to exposure to heat for long periods of time causing evaporative water loss via sweating. The physical and cognitive decrements associated with dehydration have been widely researched, however the effect of dehydration on metabolism is lesser known. As climate change is causing temperatures to rise, and metabolic diseases such as type 2 diabetes are more common, the effect of dehydration on metabolism, specifically glycemic response to meals, needs to be established for future recommendations in clinical, environmental and athletic settings.

Therefore, the aim of this study is to investigate the effect of acute exercise-induced dehydration on subsequent metabolic responses to feeding (i.e. glycaemia and insulinaemia).

Conditions
Glycaemia
Being tested
Water intake, Water restriction
Keywords
Hydration, Dehydration, Hypohydration, Glycemia, Glycaemia, Glucose control
Medical subject headings
Dehydration

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Water intakeOther

    Water ingested to fully replace sweat losses during exercise.

  • Water restrictionOther

    Water restriction to induce hypohydration of ~3% body mass through sweat losses during exercise.

Study groups in NCT06825962
Study groupRoleWhat they receive
EuhydratedExperimentalLight exercise in a hot environment with water ingested to fully replace sweat losses and maintain euhydration.
Receives: Other: Water intake
HypohydratedExperimentalLight exercise in a hot environment with water restricted to induce hypohydration of ~3% body mass through sweating.
Receives: Other: Water restriction

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Plasma glucose

    Measured using colorimetric assay from venous blood samples

    Measured: 6 hours

Secondary outcomes (11)
  1. Plasma insulin

    Measured using ELISA from venous blood samples

    Measured: 6 hours

  2. Plasma osmolality

    Measured using freezing point depression from venous blood samples

    Measured: 6 hours

  3. Plasma volume change

    Determined from haemoglobin and haematocrit measures in blood samples collected before and after drink ingestion

    Measured: 6 hours

  4. Urine volume

    Determined from urine samples collected before and after exercise

    Measured: 6 hours

  5. Body mass

    Determined from weighing participants before and after exercise

    Measured: 6 hours

  6. Urine specific gravity/osmolality

    Determined from urine samples collected before and after exercise

    Measured: 6 hours

  7. Thirst sensation

    Measured via 100 mm visual analogue scales 0 mm = not at all thirsty 100 mm = extremely thirsty

    Measured: 6 hours

  8. Hunger sensation

    Measured via 100 mm visual analogue scales 0 mm = not at all hungry 100 mm = extremely hungry

    Measured: 6 hours

  9. Fullness sensation

    Measured via 100 mm visual analogue scales 0 mm = not at all full 100 mm = extremely full

    Measured: 6 hours

  10. Core body temperature

    Measured via ingestible pill

    Measured: 6 hours

  11. Blood pressure

    Measured via and automated sphygmomanometer

    Measured: 6 hours

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Feb 2025
  2. Study startMar 2025 (estimated)
  3. Primary completionNov 2025 (estimated)
  4. Study completionDec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Randomised
Intervention model
Crossover
Model description
Randomised, crossover design
Masking
None (open label)
Enrolment
16 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06825962
Sponsor's protocol ID
2025-20370
Other IDs
2025
Status last verified
Feb 2025
First submitted
4 Feb 2025
Last updated
13 Feb 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Water intake and Water restriction in people with Glycaemia, run by Loughborough University at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 13 Feb 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Lewis J James, PhD (+44 (0) 1509 226305, L.James@lboro.ac.uk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Plasma glucose (time frame: 6 hours). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in